BioCentury | Apr 15, 2013
Company News

IntraBiotics, Pharmacia & Upjohn deal

...The companies will develop and commercialize IntraBiotics' IB-367 topical protegrin antimicrobial compound, which is in Phase...
...chemotherapy and radiation therapy. The companies will co-develop and co-promote IB-367 in the U.S., with IntraBiotics...
...license to IB-367 in all territories outside the U.S. and will pay royalties to IntraBiotics. IntraBiotics Pharmaceuticals Inc....
BioCentury | Mar 4, 2010
Cover Story

A new spin on protegrin

...pore formation in microbial membranes. 4 It has had a checkered clinical past. In 2004, IntraBiotics Pharmaceuticals Inc....
BioCentury | Sep 24, 2007
Strategy

Ship, captain and crew

...found a new calling for public shell company IntraBiotics Pharmaceuticals Inc. and its $50 million in cash. IntraBiotics...
BioCentury | Jan 1, 2007
Finance

Ebb & Flow

...to regroup: it had $158.3 million in the bank at Sept. 30. Valeant effort After IntraBiotics...
...at an end. It terminated efforts to seek alternatives and ceased all operations in 2005. IntraBiotics...
BioCentury | Jan 1, 2007
Company News

IntraBiotics, Valeant Pharmaceuticals International deal

...failed three Phase III trials for pneumonia and oral mucositis (see BioCentury, May 9, 2005). IntraBiotics Pharmaceuticals Inc....
BioCentury | Dec 27, 2006
Company News

IntraBiotics restarts R&D

IBPI said Friday that it changed its name to Ardea Biosciences and acquired three preclinical development programs covering HIV, cancer and inflammatory diseases from Valeant (VRX). IBPI had been inactive since May 2005, when it...
BioCentury | Sep 26, 2005
Company News

Onyx management update

...ONXX), Emeryville, Calif. Business: Cancer Hired: Henry Fuchs as EVP and CMO; formerly CEO of IntraBiotics Pharmaceuticals Inc....
BioCentury | Sep 19, 2005
Company News

Onyx names Fuchs CMO

...ONXX hired Henry Fuchs as EVP and CMO. Previously, Fuchs was CEO at IntraBiotics (IBPI). ONXX's...
BioCentury | Jun 27, 2005
Company News

IntraBiotics board of directors update

IntraBiotics Pharmaceuticals Inc. (IBPI), Mountain View, Calif. Business: Infectious Resigned: Ernest Mario; Gary Lyons; and Jerry Jackson WIR Staff...
BioCentury | May 9, 2005
Company News

IntraBiotics infectious news

IntraBiotics Pharmaceuticals Inc. (IBPI), Palo Alto, Calif. Business: Infectious IBPI's six remaining employees will depart, and the company will no longer actively evaluate strategic alternatives. The company will use part-time consultants to continue the minimum...
Items per page:
1 - 10 of 199
BioCentury | Apr 15, 2013
Company News

IntraBiotics, Pharmacia & Upjohn deal

...The companies will develop and commercialize IntraBiotics' IB-367 topical protegrin antimicrobial compound, which is in Phase...
...chemotherapy and radiation therapy. The companies will co-develop and co-promote IB-367 in the U.S., with IntraBiotics...
...license to IB-367 in all territories outside the U.S. and will pay royalties to IntraBiotics. IntraBiotics Pharmaceuticals Inc....
BioCentury | Mar 4, 2010
Cover Story

A new spin on protegrin

...pore formation in microbial membranes. 4 It has had a checkered clinical past. In 2004, IntraBiotics Pharmaceuticals Inc....
BioCentury | Sep 24, 2007
Strategy

Ship, captain and crew

...found a new calling for public shell company IntraBiotics Pharmaceuticals Inc. and its $50 million in cash. IntraBiotics...
BioCentury | Jan 1, 2007
Finance

Ebb & Flow

...to regroup: it had $158.3 million in the bank at Sept. 30. Valeant effort After IntraBiotics...
...at an end. It terminated efforts to seek alternatives and ceased all operations in 2005. IntraBiotics...
BioCentury | Jan 1, 2007
Company News

IntraBiotics, Valeant Pharmaceuticals International deal

...failed three Phase III trials for pneumonia and oral mucositis (see BioCentury, May 9, 2005). IntraBiotics Pharmaceuticals Inc....
BioCentury | Dec 27, 2006
Company News

IntraBiotics restarts R&D

IBPI said Friday that it changed its name to Ardea Biosciences and acquired three preclinical development programs covering HIV, cancer and inflammatory diseases from Valeant (VRX). IBPI had been inactive since May 2005, when it...
BioCentury | Sep 26, 2005
Company News

Onyx management update

...ONXX), Emeryville, Calif. Business: Cancer Hired: Henry Fuchs as EVP and CMO; formerly CEO of IntraBiotics Pharmaceuticals Inc....
BioCentury | Sep 19, 2005
Company News

Onyx names Fuchs CMO

...ONXX hired Henry Fuchs as EVP and CMO. Previously, Fuchs was CEO at IntraBiotics (IBPI). ONXX's...
BioCentury | Jun 27, 2005
Company News

IntraBiotics board of directors update

IntraBiotics Pharmaceuticals Inc. (IBPI), Mountain View, Calif. Business: Infectious Resigned: Ernest Mario; Gary Lyons; and Jerry Jackson WIR Staff...
BioCentury | May 9, 2005
Company News

IntraBiotics infectious news

IntraBiotics Pharmaceuticals Inc. (IBPI), Palo Alto, Calif. Business: Infectious IBPI's six remaining employees will depart, and the company will no longer actively evaluate strategic alternatives. The company will use part-time consultants to continue the minimum...
Items per page:
1 - 10 of 199